NIR-II Fluorescence Probe Based on Polyamidoamine Dendrimers for Immunotherapy as Antigen Carrier

Chao Wang,Peng-fei Sun,Qu-li Fan
DOI: https://doi.org/10.11777/j.issn1000-3304.2021.21192
2022-01-01
Acta Polymerica Sinica
Abstract:In this study, we design and synthesize a second near-infrared window (NIR-II) fluorescence molecule (TTQ-F-PAIVIAM) by modifying polyamidoamine dendrimers on donor-acceptor-donor (D-A-D) NIR- II fluorescence core TTQ-F. TTQ-F-PAIVIAM can realize fluorescence image during 900-1200 nm excited by 808 nm laser, and shows outstanding photostability. According to the dynamic light scattering (DLS) and transmission electron microscopy (TEM) results, the hydrodynamic size of TTQ-F-PAMAM was approximately 45 nm. As shown in the NIR-II images of TTQ-F-PAMAM at different depths, the tissue penetration of NIR-II fluorescence signal from TTQ-F-PAMAM can reach up to 4 mm. Owing to the polyamidoaminc dendrimers, TTQ-F-PAMAM showed great antigen-loading capacity. And the MTT assay showed that TTQ-F-PAMAM exerted lower cell toxicity on cells. Ovalbumin (OVA), a model antigen in immune research, could be adsorbed onto TTQ-F-PAMAM by electrostatic binding. The loading capacity of TTQ-F-PAMAM was 16.43%. TTQ-F-PAMAM@OVA, the nanoparticles loaded with antigen can easier transported to antigen presenting cells than free OVA. Dendritic cell (DC) is the major antigen presenting cell in innate immunity and plays an important role in cancer suppression. After cell uptake of TTQ-F-PAMAM@OVA, the antigen induces the maturation of DC and promotes specific anti-tumor immunity. Compared with other groups, the percentage of both CD80 and CD86 significantly increased after cultured with TTQ-F-PAMAM@OVA. These cells activated by TTQ-F-PAMAM can release tumor necrosis factor-alpha (TNF-alpha) and interleukin-12p70 (IL-12p70). The secretion of TNF-alpha and IL-12p70 from DCs incubated with TTQ-F-PAMAM@OVA was much higher than that incubated with free TTQ-F-PAMAM or OVA. TTQ-F-PAMAM was used not only as a NIR-II fluorescence probe, but also as the delivery of proteins to antigen presenting cells. This treatment strategy may greatly improve the efficiency of cancer therapy and provides a new method for immunotherapy research. [GRAPHICS] .
What problem does this paper attempt to address?